Cargando…
Identification of Patients With Locally Advanced Gastric Cancer Who May Benefit From Adjuvant Chemoradiotherapy After D2 dissection: A Propensity Score Matching Analysis
BACKGROUND: One of the most controversial areas in gastrointestinal oncology is the benefit of postoperative chemoradiotherapy (CRT) over chemotherapy (CT) alone after D2 dissection of locally advanced gastric cancer (LAGC). We aimed to identify the LAGC patients who may benefit from adjuvant CRT. M...
Autores principales: | Wang, Shu-Bei, Qi, Wei-Xiang, Chen, Jia-Yi, Xu, Cheng, Cao, Wei-Guo, Cai, Rong, Cao, Lu, Cai, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047641/ https://www.ncbi.nlm.nih.gov/pubmed/33869049 http://dx.doi.org/10.3389/fonc.2021.648978 |
Ejemplares similares
-
Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection
por: Wang, Shu-Bei, et al.
Publicado: (2022) -
Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
por: Girardi, Daniel M., et al.
Publicado: (2018) -
Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Wang, Qifeng, et al.
Publicado: (2020) -
Adjuvant chemoradiotherapy vs chemotherapy for resectable biliary tract cancer: a propensity score matching analysis based on the SEER database
por: Zhu, Yueting, et al.
Publicado: (2023) -
Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Chang, Yi-Lin, et al.
Publicado: (2022)